Commonwealth Equity Services
VIR icon

Commonwealth Equity Services’s Vir Biotechnology VIR Stock Holding History

Commonwealth Equity Services’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-56,179
Closed -$503K – 4571
2026
Q1 		$503K Sell
56,179
-9,562
-15% -$76.2K ﹤0.01% 3200
2025
Q4 		$396K Hold
65,741
– – ﹤0.01% 3390
2025
Q3 		$375K Sell
65,741
-304
-0.5% -$1.55K ﹤0.01% 3434
2025
Q2 		$333K Sell
66,045
-1,038
-2% -$5.57K ﹤0.01% 3497
2025
Q1 		$435K Sell
67,083
-283
-0.4% -$2.52K ﹤0.01% 3140
2024
Q4 		$494K Sell
67,366
-1,469
-2% -$11.6K ﹤0.01% 2958
2024
Q3 		$516K Buy
68,835
+5,600
+9% +$48.6K ﹤0.01% 2869
2024
Q2 		$563K Sell
63,235
-3,083
-5% -$29.6K ﹤0.01% 2736
2024
Q1 		$672K Sell
66,318
-100
-0.2% -$1.02K ﹤0.01% 2563
2023
Q4 		$668K Sell
66,418
-1,024
-2% -$9.36K ﹤0.01% 2472
2023
Q3 		$632K Sell
67,442
-2,342
-3% -$33.4K ﹤0.01% 2399
2023
Q2 		$1.71M Hold
69,784
– – ﹤0.01% 1734
2023
Q1 		$1.62M Sell
69,784
-9,384
-12% -$240K ﹤0.01% 1691
2022
Q4 		$2M Sell
79,168
-6,130
-7% -$150K ﹤0.01% 1500
2022
Q3 		$1.64M Buy
85,298
+523
+0.6% +$13.3K ﹤0.01% 1558
2022
Q2 		$2.16M Hold
84,775
– – 0.01% 1395
2022
Q1 		$2.18M Sell
84,775
-845
-1% -$25.1K 0.01% 1445
2021
Q4 		$3.58M Sell
85,620
-1,621
-2% -$63.5K 0.01% 1107
2021
Q3 		$3.8M Sell
87,241
-23,088
-21% -$1,000K 0.01% 1031
2021
Q2 		$5.22M Buy
110,329
+20,901
+23% +$950K 0.01% 833
2021
Q1 		$4.58M Sell
89,428
-57,376
-39% -$3.09M 0.01% 829
2020
Q4 		$3.93M Sell
146,804
-514
-0.3% -$16.7K 0.01% 848
2020
Q3 		$5.06M Sell
147,318
-12,121
-8% -$522K 0.02% 641
2020
Q2 		$6.53M Buy
+159,439
New +$5.35M 0.02% 538

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Commonwealth Equity Services's VIR Position: Q2 2026 in Review

Commonwealth Equity Services sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 56,179 shares — an estimated $503K sold.

Commonwealth Equity Services first reported a position in VIR in Q2 2020 and held it in 24 quarters. The position peaked at $6.53M in Q2 2020. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Commonwealth Equity Services reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 56,179 Vir Biotechnology shares in Q2 2026, an estimated $503K.
  • Commonwealth Equity Services first reported a position in Vir Biotechnology in Q2 2020 and held it in 24 quarters.
  • Commonwealth Equity Services's Vir Biotechnology position peaked at $6.53M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.